GUERBET (GBT.PA) Stock Fundamental Analysis
Europe - EPA:GBT - FR0000032526 - Common Stock
13.92 EUR
-0.04 (-0.29%)
We assign a fundamental rating of 4 out of 10 to GBT. GBT was compared to 60 industry peers in the Health Care Equipment & Supplies industry. GBT has only an average score on both its financial health and profitability. GBT has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
GBT had positive earnings in the past year.
In the past year GBT had a positive cash flow from operations.
GBT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years GBT had a positive operating cash flow.
1.2 Ratios
GBT's Return On Assets of 1.55% is in line compared to the rest of the industry. GBT outperforms 41.67% of its industry peers.
GBT has a Return On Equity (4.08%) which is comparable to the rest of the industry.
GBT has a Return On Invested Capital (4.48%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for GBT is below the industry average of 9.00%.
The 3 year average ROIC (4.08%) for GBT is below the current ROIC(4.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROIC | 4.48% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
GBT has a Profit Margin of 1.91%. This is comparable to the rest of the industry: GBT outperforms 41.67% of its industry peers.
In the last couple of years the Profit Margin of GBT has declined.
With a Operating Margin value of 5.89%, GBT is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of GBT has declined.
Looking at the Gross Margin, with a value of 77.94%, GBT belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
GBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
The number of shares outstanding for GBT remains at a similar level compared to 1 year ago.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
GBT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.09 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.09, GBT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
GBT has a debt to FCF ratio of 16.18. This is a negative value and a sign of low solvency as GBT would need 16.18 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.18, GBT is in line with its industry, outperforming 46.67% of the companies in the same industry.
A Debt/Equity ratio of 0.89 indicates that GBT is somewhat dependend on debt financing.
GBT has a Debt to Equity ratio of 0.89. This is in the lower half of the industry: GBT underperforms 78.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.66
WACC6.77%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT's Current ratio of 2.32 is fine compared to the rest of the industry. GBT outperforms 71.67% of its industry peers.
GBT has a Quick Ratio of 1.13. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
GBT has a Quick ratio (1.13) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The earnings per share for GBT have decreased strongly by -34.20% in the last year.
GBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.50% yearly.
The Revenue has been growing slightly by 7.05% in the past year.
Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
3.2 Future
Based on estimates for the next years, GBT will show a decrease in Earnings Per Share. The EPS will decrease by -6.01% on average per year.
Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.37% on average per year.
EPS Next Y-70.82%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPS Next 5Y-6.01%
Revenue Next Year-3.65%
Revenue Next 2Y-0.26%
Revenue Next 3Y1.17%
Revenue Next 5Y3.37%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.96 indicates a reasonable valuation of GBT.
Compared to the rest of the industry, the Price/Earnings ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 96.67% of the companies listed in the same industry.
GBT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.86.
The Price/Forward Earnings ratio is 18.54, which indicates a rather expensive current valuation of GBT.
GBT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GBT is cheaper than 70.00% of the companies in the same industry.
GBT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.96 | ||
| Fwd PE | 18.54 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 96.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.26 | ||
| EV/EBITDA | 3.34 |
4.3 Compensation for Growth
A cheap valuation may be justified as GBT's earnings are expected to decrease with -12.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
5. Dividend
5.1 Amount
GBT has a Yearly Dividend Yield of 2.69%.
In the last 3 months the price of GBT has falen by -37.96%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
GBT's Dividend Yield is rather good when compared to the industry average which is at 2.13. GBT pays more dividend than 90.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, GBT has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
39.20% of the earnings are spent on dividend by GBT. This is a low number and sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP39.2%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPA:GBT (10/6/2025, 5:19:18 PM)
13.92
-0.04 (-0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners15.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap175.95M
Analysts46
Price Target18.61 (33.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP39.2%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30.48%
PT rev (3m)-33.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-60.62%
EPS NY rev (3m)-70.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.99%
Revenue NY rev (3m)-6.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.96 | ||
| Fwd PE | 18.54 | ||
| P/S | 0.21 | ||
| P/FCF | 7.26 | ||
| P/OCF | 2.17 | ||
| P/B | 0.45 | ||
| P/tB | 0.61 | ||
| EV/EBITDA | 3.34 |
EPS(TTM)1.27
EY9.12%
EPS(NY)0.75
Fwd EY5.39%
FCF(TTM)1.92
FCFY13.77%
OCF(TTM)6.43
OCFY46.16%
SpS66.54
BVpS31.19
TBVpS22.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROCE | 6.33% | ||
| ROIC | 4.48% | ||
| ROICexc | 5.17% | ||
| ROICexgc | 6.14% | ||
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% | ||
| FCFM | 2.88% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexcg growth 3Y-4.82%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Debt/EBITDA | 2.86 | ||
| Cap/Depr | 77.91% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | 2.42 | ||
| Cash Conversion | 66.19% | ||
| Profit Quality | 150.63% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 2.09 |
F-Score5
WACC6.77%
ROIC/WACC0.66
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
EPS Next Y-70.82%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPS Next 5Y-6.01%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
Revenue Next Year-3.65%
Revenue Next 2Y-0.26%
Revenue Next 3Y1.17%
Revenue Next 5Y3.37%
EBIT growth 1Y28.18%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year61.5%
EBIT Next 3Y25.44%
EBIT Next 5Y21.2%
FCF growth 1Y182.76%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y196.03%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%